MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 138 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 2.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $109,000 | -59.6% | 87,700 | 0.0% | 0.09% | -60.5% |
Q1 2017 | $270,000 | -14.8% | 87,700 | +12.9% | 0.24% | -18.5% |
Q4 2016 | $317,000 | -39.6% | 77,700 | -6.0% | 0.29% | -40.9% |
Q3 2016 | $525,000 | +17.7% | 82,700 | 0.0% | 0.49% | +13.0% |
Q2 2016 | $446,000 | -35.5% | 82,700 | 0.0% | 0.44% | -45.7% |
Q1 2016 | $692,000 | +6.0% | 82,700 | 0.0% | 0.80% | +10.0% |
Q4 2015 | $653,000 | -7.2% | 82,700 | 0.0% | 0.73% | -5.8% |
Q3 2015 | $704,000 | -37.3% | 82,700 | -8.8% | 0.78% | -29.1% |
Q2 2015 | $1,122,000 | +4.1% | 90,700 | 0.0% | 1.10% | +8.8% |
Q1 2015 | $1,078,000 | +5.2% | 90,700 | 0.0% | 1.01% | +8.4% |
Q4 2014 | $1,025,000 | +22.9% | 90,700 | -4.5% | 0.93% | +11.4% |
Q3 2014 | $834,000 | +16.8% | 95,001 | -3.1% | 0.83% | +25.6% |
Q2 2014 | $714,000 | +44.5% | 98,001 | 0.0% | 0.66% | +39.5% |
Q1 2014 | $494,000 | -5.4% | 98,001 | 0.0% | 0.48% | -3.4% |
Q4 2013 | $522,000 | +40.7% | 98,001 | 0.0% | 0.49% | +29.7% |
Q3 2013 | $371,000 | -43.9% | 98,001 | 0.0% | 0.38% | -46.6% |
Q2 2013 | $661,000 | – | 98,001 | – | 0.71% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lagoda Investment Management, L.P. | 775,571 | $2,389,000 | 0.93% |
KEMPNER CAPITAL MANAGEMENT INC. | 148,985 | $459,000 | 0.31% |
Yakira Capital Management, Inc. | 248,420 | $765,000 | 0.27% |
GARRISON BRADFORD & ASSOCIATES INC | 87,700 | $270,000 | 0.24% |
Cannell & Co. | 1,212,478 | $3,734,000 | 0.13% |
LeJeune Puetz Investment Counsel LLC | 3,976 | $180,000 | 0.13% |
ALPINE WOODS CAPITAL INVESTORS, LLC | 726,000 | $2,236,000 | 0.12% |
Virtus ETF Advisers LLC | 198,735 | $612,000 | 0.11% |
STONERIDGE INVESTMENT PARTNERS LLC | 199,227 | $614,000 | 0.08% |
Birchview Capital, LP | 44,000 | $136,000 | 0.08% |